Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Abivax SA - American Depositary Shares (NQ:ABVX)

114.03 -12.45 (-9.85%)

Streaming Delayed Price Updated: 12:35 PM EST, Jan 8, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	2,696,156
Open	125.10
Bid (Size)	113.92 (200)
Ask (Size)	114.13 (100)
Prev. Close	126.48
Today's Range	108.95 - 125.10
52wk Range	4.770 - 148.83
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Abivax Provides 2026 Corporate Outlook

January 07, 2026

From Abivax

Via GlobeNewswire

Is Cidara Therapeutics a Buy After HighVista Strategies Initiated a Position in the Stock? ↗

January 02, 2026

Is Cidara Therapeutics a Buy After HighVista Strategies Initiated a Position in the Stock?

Via The Motley Fool

Performance

YTD	-14.8%	-14.8%
1 Month	-0.9%	-0.9%
3 Month	+31.8%	+31.8%
6 Month	+1272.1%	+1272.1%
1 Year	+1533.6%	+1533.6%

More News

Could This Potential Move Boost Eli Lilly's Prospects? ↗

December 31, 2025

Via The Motley Fool

The 2025 Growth Postgame: Analyzing the AI Supercycle and Preparing for the 2026 'Agentic' Pivot

December 26, 2025

Via MarketMinute

How Abivax Went From Biotech Nobody To M&A Bullseye After A Single Blockbuster Readout This Year ↗

December 24, 2025

Via Stocktwits

Nasdaq, S&P 500 Futures Head Into Christmas Eve With Caution: Why ASTS, DVAX, ABVX, PATH, GOOGL Are On Traders' Radar Today ↗

December 24, 2025

Via Stocktwits

The Next Big Buyout? Abivax Emerges as a Premier M&A Contender for 2026 Amidst Biotech Consolidation Wave

December 23, 2025

Via MarketMinute

Why Abivax Stock Was on Fire Today ↗

December 22, 2025

Via The Motley Fool

Is Rapport Therapeutics Stock a Buy After Investment Firm Cormorant Raised Its Stake Over $60 Million? ↗

December 22, 2025

Via The Motley Fool

Abivax to be Added to Nasdaq Biotechnology Index

December 18, 2025

From Abivax

Via GlobeNewswire

The Great Rotation: Small-Cap Growth Surges as Investors Ditch Defensive Safety for Post-Fed Gains

December 18, 2025

Via MarketMinute

Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings

December 17, 2025

From Abivax

Via GlobeNewswire

Abivax Presents Third Quarter 2025 Financial Results

December 15, 2025

From Abivax

Via GlobeNewswire

2 Under-the-Radar Stocks That Have Soared This Year ↗

December 09, 2025

Via The Motley Fool

This Biotech Fund Just Made a $22 Million Bet on Pharvaris Stock — Is It a Buy? ↗

December 09, 2025

Via The Motley Fool

Hedge Fund Boosts Stake in Amylyx Stock to $63 Million — Should Investors Follow? ↗

December 09, 2025

Via The Motley Fool

Why a Biotech Fund Made Dyne Therapeutics One of Its Biggest Stock Bets ↗

December 09, 2025

Via The Motley Fool

6 Healthcare Stocks With Strong Upward Momentum ↗

November 18, 2025

Via Benzinga

This Biotech Fund Has an $85 Million Bet on Amylyx as Stock Surges 180% and Co-CEOs Tease 'Transformational' Year Ahead ↗

November 17, 2025

Via The Motley Fool

This Biotech Fund Made a New $40 Million Bet on Liquidia Amid Blockbuster Commercial Drug Launch ↗

November 17, 2025

Via The Motley Fool

Centessa Stock Has Surged 77% Over the Past Year — But a Top Biotech Fund Is Still Buying ↗

November 17, 2025

Via The Motley Fool

This Fund Sold $49 Million of Cidara Stock — Then Merck Announced a $9.2 Billion Takeover ↗

November 17, 2025

Via The Motley Fool

This Brinker International Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗

November 06, 2025

Via Benzinga

Abivax Announces Patient-Reported Outcomes Data from the Phase 3 ABTECT Induction Trials of Obefazimod, Demonstrating Significant Improvements in Quality of Life for Patients with Moderate-to-Severely Active Ulcerative Colitis

November 03, 2025

From Abivax

Via GlobeNewswire

Tilray Brands Posts Upbeat Results, Joins Byrna Technologies, Delta Air Lines And Other Big Stocks Moving Higher On Thursday ↗

October 09, 2025

Via Benzinga

Frequently Asked Questions

Is Abivax SA - American Depositary Shares publicly traded?

Yes, Abivax SA - American Depositary Shares is publicly traded.

What exchange does Abivax SA - American Depositary Shares trade on?

Abivax SA - American Depositary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Abivax SA - American Depositary Shares?

The ticker symbol for Abivax SA - American Depositary Shares is ABVX on the Nasdaq Stock Market

What is the current price of Abivax SA - American Depositary Shares?

The current price of Abivax SA - American Depositary Shares is 114.03

When was Abivax SA - American Depositary Shares last traded?

The last trade of Abivax SA - American Depositary Shares was at 01/08/26 12:35 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.